John A. Glaspy, Veena Charu, Donghan Luo, Victor Moyo, Marc Kamin and Francois E. Wilhelm Initiation of epoetin-α therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy Cancer 115
Version of Record online: 23 JAN 2009 | DOI: 10.1002/cncr.24127
An initial dose of epoetin-α 120,000 U once every 3 weeks was well tolerated and effective for maintenance of hemoglobin levels in the management of chemotherapy-induced anemia. Early intervention (hemoglobin between 11.0 and 12.0 g/dL) and standard intervention (hemoglobin below 11.0 g/dL) with epoetin-α once every 3 weeks had similar safety and effectiveness.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field